MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,092,555 | -31.9% | 1,952,742 | +0.2% | 0.00% | -33.3% |
| Q2 2023 | $8,947,631 | -8.2% | 1,949,375 | -1.0% | 0.00% | 0.0% |
| Q1 2023 | $9,742,793 | -9.3% | 1,968,241 | +0.0% | 0.00% | -25.0% |
| Q4 2022 | $10,745,602 | -35.0% | 1,968,059 | -22.6% | 0.00% | -33.3% |
| Q3 2022 | $16,526,000 | +47.6% | 2,542,463 | +7.4% | 0.01% | +50.0% |
| Q2 2022 | $11,200,000 | -14.4% | 2,367,838 | +26.5% | 0.00% | 0.0% |
| Q1 2022 | $13,087,000 | -29.5% | 1,872,197 | +2.8% | 0.00% | -20.0% |
| Q4 2021 | $18,554,000 | -2.7% | 1,820,805 | +16.6% | 0.01% | -16.7% |
| Q3 2021 | $19,060,000 | – | 1,561,056 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |